These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6242352)

  • 1. Chemotherapeutic sensitivity of acute lymphoblastic leukemia cells in culture: correlation with clinical efficacy on donor patients.
    Beranek JT; Ohnuma T; Takahashi I; Minowada J; Holland JF
    Cancer Drug Deliv; 1984; 1(4):307-19. PubMed ID: 6242352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by chemotherapeutic agents of human bone marrow progenitor cells and clonogenic cells of a lymphoblastic cell line.
    Williams CK; Ohnuma T; Holland JF
    Eur J Cancer (1965); 1981 May; 17(5):519-26. PubMed ID: 6975210
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of drugs for elimination of leukemic cells from the bone marrow of patients with acute leukemia.
    Auber ML; Horwitz LJ; Blaauw A; Khorana S; Tucker S; Woods T; Warmuth M; Dicke KA; McCredie KB; Spitzer G
    Blood; 1988 Jan; 71(1):166-72. PubMed ID: 2446678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cell density on drug-induced cell kill kinetics in vitro (inoculum effect).
    Ohnuma T; Arkin H; Holland JF
    Br J Cancer; 1986 Sep; 54(3):415-21. PubMed ID: 2428392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of in vitro sensitivity of acute myeloid leukemia precursors to mitoxantrone, 4'deoxydoxorubicin, 4-demethoxydaunorubicin and daunorubicin.
    Schölzel C; van Putten W; Löwenberg B
    Leuk Res; 1986; 10(12):1455-9. PubMed ID: 3467144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro sensitivity testing of human kidney tumors to cytostatic drugs with a rapid in vitro test].
    de Riese W; Aeikens B; Lenis G; Schindler E
    Urol Int; 1986; 41(2):112-6. PubMed ID: 3088790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro study of sensitivity of leukemic cells to cytotoxic drugs (anticytogram)].
    Zittoun R; Bouchard M; Facquet-Danis J; Diaz-Mayo C; Percie-du-Sert M; Bousser J
    Nouv Presse Med; 1975 Feb; 4(6):401-4. PubMed ID: 1055355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative description of morphologic changes effected by antileukemic agents in L1210 leukemia cells.
    Iwasaki H; Liu YP; Nojyo Y; Ueda T; Nakamura T
    Anticancer Res; 1995; 15(1):133-9. PubMed ID: 7733623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of imatinib in cells from patients with adult acute lymphoblastic leukemia.
    Hallböök H; Barbany G; Aleskog A; Björnberg A; Larsson R; Sundström C; Lindhagen E
    Anticancer Drugs; 2005 Jul; 16(6):631-4. PubMed ID: 15930891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.
    Mirabelli CK; Sung CM; McCabe FL; Faucette LF; Crooke ST; Johnson RK
    Cancer Res; 1988 Oct; 48(19):5447-54. PubMed ID: 3046738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronization and recruitment in acute leukemia.
    Lampkin BC; Nagao T; Mauer AM
    J Clin Invest; 1971 Oct; 50(10):2204-14. PubMed ID: 5286686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human tumor clonogenic assay in human breast cancer].
    Kobayashi T; Kuraishi Y; Aiba K; Inoue K
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1566-72. PubMed ID: 3927846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
    Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cancer chemotherapeutic agents on fibrin formation and stabilization in vitro.
    Komp DM; Lyles RL; Boyd TH; Stoner GE; Cox BJ
    Pediatr Res; 1974 Feb; 8(2):75-81. PubMed ID: 4810511
    [No Abstract]   [Full Text] [Related]  

  • 15. Short-term in vitro sensitivity testing in acute leukemia.
    Schwarzmeier JD; Pirker R; Paietta E
    Recent Results Cancer Res; 1984; 94():116-26. PubMed ID: 6593775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the drug sensitivity of acute nonlymphocytic leukaemia using the in vitro clonogenic assay.
    Preisler HD; Azarnia N
    Br J Haematol; 1984 Dec; 58(4):633-40. PubMed ID: 6518136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
    Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
    Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of chemotherapeutic drugs on human and murine hematopoietic progenitors in vitro.
    Horikoshi A; Murphy MJ
    Chemotherapy; 1982; 28(6):480-501. PubMed ID: 7160235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase and anthracyclines.
    Ronghe M; Burke GA; Lowis SP; Estlin EJ
    Cancer Treat Rev; 2001 Dec; 27(6):327-37. PubMed ID: 11908926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia.
    Lugthart S; Cheok MH; den Boer ML; Yang W; Holleman A; Cheng C; Pui CH; Relling MV; Janka-Schaub GE; Pieters R; Evans WE
    Cancer Cell; 2005 Apr; 7(4):375-86. PubMed ID: 15837626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.